Barclays PLC Zai Lab LTD Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Barclays PLC holds 31,286 shares of ZLAB stock, worth $556,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,286
Previous 600
5114.33%
Holding current value
$556,265
Previous $16,000
3037.5%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ZLAB
# of Institutions
123Shares Held
39.8MCall Options Held
41.2KPut Options Held
190K-
Wellington Management Group LLP Boston, MA6.66MShares$118 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA5.68MShares$101 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$78.7 Million0.04% of portfolio
-
Woodline Partners LP San Francisco, CA2.6MShares$46.2 Million0.4% of portfolio
-
Viking Global Investors LP2.05MShares$36.4 Million0.12% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $1.74B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...